Rick W / Saturday, April 19, 2025 / Categories: Artificial Intelligence Isomorphic Labs Rethinks Drug Discovery With AI Isomorphic Labs is reimagining the drug discovery process with an AI-first approach. At the heart of this work is a new way of thinking about biology. Max Jaderberg, chief AI officer, and Sergei Yakneen, chief technology officer at Isomorphic Labs joined the AI Podcast to explain why they look at biology as an information processing Read Article Previous Article Watch the FabCon Las Vegas keynote recording now! Next Article MIT’s McGovern Institute is shaping brain science and improving human lives on a global scale Print 143 Tags: AIBIDrug Discovery